Macquarie Group LTD United Therapeutics Corp Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Macquarie Group LTD holds 35,142 shares of UTHR stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,142
Previous 33,480 4.96%
Holding current value
$12.7 Million
Previous $10.7 Million 18.08%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $516,948 - $604,220
1,662 Added 4.96%
35,142 $12.6 Million
Q2 2024

Aug 09, 2024
SELL
$228.26 - $319.04 $2.18 Million - $3.04 Million
-9,535 Reduced 22.17%
33,480 $10.7 Million
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $4.94 Million - $5.85 Million
-23,436 Reduced 35.27%
43,015 $9.88 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $6.46 Million - $7.73 Million
-30,075 Reduced 31.16%
66,451 $14.6 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $637,790 - $747,450
3,011 Added 3.22%
96,526 $21.8 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $92,335 - $104,845
450 Added 0.48%
93,515 $20.6 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $5.38 Million - $6.97 Million
-25,245 Reduced 21.34%
93,065 $20.8 Million
Q4 2022

Feb 21, 2023
SELL
$205.95 - $280.43 $1.71 Million - $2.32 Million
-8,281 Reduced 6.54%
118,310 $32.9 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $117,100 - $140,641
-576 Reduced 0.45%
126,591 $26.6 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $5.35 Million - $7.38 Million
30,603 Added 31.69%
127,167 $30 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $839,946 - $1 Million
4,670 Added 5.08%
96,564 $17.8 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $1.24 Million - $1.54 Million
-7,279 Reduced 7.34%
91,894 $16.5 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $68,503 - $77,808
-445 Reduced 0.45%
99,173 $16.6 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $19,355 - $28,840
190 Added 0.19%
99,618 $15.1 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $15,784 - $19,138
-158 Reduced 0.16%
99,428 $10 Million
Q2 2020

Aug 11, 2020
BUY
$92.74 - $125.82 $1 Million - $1.36 Million
10,786 Added 12.15%
99,586 $12.1 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $62,648 - $76,272
800 Added 0.91%
88,800 $7.82 Million
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $2.1 Million - $2.41 Million
28,010 Added 46.69%
88,000 $7.02 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $882,296 - $1.4 Million
-11,600 Reduced 16.2%
59,990 $4.68 Million
Q1 2019

May 15, 2019
SELL
$107.15 - $126.84 $4.42 Million - $5.23 Million
-41,210 Reduced 36.53%
71,590 $8.4 Million
Q4 2018

Feb 15, 2019
BUY
$101.4 - $128.73 $10.2 Million - $13 Million
101,000 Added 855.93%
112,800 $12.3 Million
Q3 2018

Nov 15, 2018
SELL
$113.81 - $129.46 $398,335 - $453,110
-3,500 Reduced 22.88%
11,800 $1.51 Million
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $10,114 - $11,831
100 Added 0.66%
15,300 $1.73 Million
Q1 2018

May 11, 2018
SELL
$107.21 - $151.94 $192,978 - $273,492
-1,800 Reduced 10.59%
15,200 $1.71 Million
Q4 2017

Feb 15, 2018
BUY
$118.58 - $151.28 $509,894 - $650,504
4,300 Added 33.86%
17,000 $2.5 Million
Q3 2017

Nov 08, 2017
BUY
$114.6 - $136.81 $1.46 Million - $1.74 Million
12,700
12,700 $1.49 Million

Others Institutions Holding UTHR

# of Institutions
673
Shares Held
42.2M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email